BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12113801)

  • 21. [Clarification of the pathogenesis and development of clinical examination for allergic diseases].
    Izuhara K; Kanaji S; Ohta S; Arima K
    Rinsho Byori; 2007 Apr; 55(4):369-74. PubMed ID: 17511268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The other side of the coin: the protective role of the TH2 cytokines.
    Finkelman FD; Urban JF
    J Allergy Clin Immunol; 2001 May; 107(5):772-80. PubMed ID: 11344341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anti-asthma therapies: suppression of the effect of interleukin (IL)-4 and IL-5.
    Kips JC; Tournoy KG; Pauwels RA
    Eur Respir J; 2001 Mar; 17(3):499-506. PubMed ID: 11405532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and cellular mechanisms of allergic disease.
    Broide DH
    J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S65-71. PubMed ID: 11498675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Innate Th2-type immune responses and the natural helper cell, a newly identified lymphocyte population.
    Koyasu S; Moro K
    Curr Opin Allergy Clin Immunol; 2011 Apr; 11(2):109-14. PubMed ID: 21301328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells.
    Lordan JL; Bucchieri F; Richter A; Konstantinidis A; Holloway JW; Thornber M; Puddicombe SM; Buchanan D; Wilson SJ; Djukanović R; Holgate ST; Davies DE
    J Immunol; 2002 Jul; 169(1):407-14. PubMed ID: 12077271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils.
    Bracke M; Dubois GR; Bolt K; Bruijnzeel PL; Vaerman JP; Lammers JW; Koenderman L
    J Immunol; 1997 Aug; 159(3):1459-65. PubMed ID: 9233644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13.
    Fallon PG; Jolin HE; Smith P; Emson CL; Townsend MJ; Fallon R; Smith P; McKenzie AN
    Immunity; 2002 Jul; 17(1):7-17. PubMed ID: 12150887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines as targets for the inhibition of eosinophilic inflammation.
    Hogan SP; Foster PS
    Pharmacol Ther; 1997; 74(3):259-83. PubMed ID: 9352584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity.
    Foster PS; Hogan SP; Matthaei KI; Young IG
    Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():55-61. PubMed ID: 9698916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-13 and the IL-13 receptor as therapeutic targets for asthma and allergic disease.
    Mitchell J; Dimov V; Townley RG
    Curr Opin Investig Drugs; 2010 May; 11(5):527-34. PubMed ID: 20419598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of production of interleukin-4 and interleukin-5.
    Sewell WA; Mu HH
    Immunol Cell Biol; 1996 Jun; 74(3):274-7. PubMed ID: 8799728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of the role of interleukin-17 and the interleukin-20 family in inflammatory allergic skin diseases.
    Hofmann MA; Kiecker F; Zuberbier T
    Curr Opin Allergy Clin Immunol; 2016 Oct; 16(5):451-7. PubMed ID: 27490126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-6 receptor α defines effector memory CD8+ T cells producing Th2 cytokines and expanding in asthma.
    Lee N; You S; Shin MS; Lee WW; Kang KS; Kim SH; Kim WU; Homer RJ; Kang MJ; Montgomery RR; Dela Cruz CS; Shaw AC; Lee PJ; Chupp GL; Hwang D; Kang I
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1383-94. PubMed ID: 25390970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
    Kim SH; Hong JH; Lee YC
    Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukins in immunologic and allergic diseases.
    Herrod HG
    Ann Allergy; 1989 Oct; 63(4):269-72. PubMed ID: 2679243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cytokines in allergic inflammatory process].
    Rutkowski R; Moniuszko T
    Postepy Hig Med Dosw; 2001; 55(4):587-603. PubMed ID: 11766232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IL-13 and its receptor in allergy and inflammatory responses.
    de Vries JE
    J Allergy Clin Immunol; 1998 Aug; 102(2):165-9. PubMed ID: 9723655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases.
    Onodera A; Kokubo K; Okano M; Onoue M; Kiuchi M; Iwamura C; Iinuma T; Kimura MY; Ebihara N; Hanazawa T; Nakayama T; Hirahara K
    Pharmacol Ther; 2023 Jul; 247():108445. PubMed ID: 37201737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.